A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Female Participants With Fabry Disease
Clinical trial NCT00304512 · COMPLETED
Trial details
- NCT number
- NCT00304512
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-07
- Primary completion
- 2008-05-09
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.